These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27436335)

  • 1. Antiphospholipid Syndrome On Cloud (APSOnCloud): web-based monitoring of oral anticoagulation.
    Nogueira F; Signorelli F; Levy RA
    Lupus; 2017 Feb; 26(2):179-185. PubMed ID: 27436335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of direct oral anticoagulants in antiphospholipid syndrome.
    Cohen H; Efthymiou M; Isenberg DA
    J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cessation of oral anticoagulants in antiphospholipid syndrome.
    Comarmond C; Jego P; Veyssier-Belot C; Marie I; Mekinian A; Elmaleh-Sachs A; Leroux G; Saadoun D; Oziol E; Fraisse T; Hyvernat H; Thiercein-Legrand MF; Sarrot-Reynauld F; Ferreira-Maldent N; de Menthon M; Goujard C; Khau D; Nguen Y; Monnier S; Michon A; Castel B; Decaux O; Piette JC; Cacoub P
    Lupus; 2017 Oct; 26(12):1291-1296. PubMed ID: 28355985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome.
    Isert M; Miesbach W; Schüttfort G; Weil Y; Tirneci V; Kasper A; Weber A; Lindhoff-Last E; Herrmann E; Linnemann B
    Ann Hematol; 2015 Aug; 94(8):1291-9. PubMed ID: 25859986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative management of patients with antiphospholipid syndrome: a single-center experience.
    Atisha-Fregoso Y; Espejo-Poox E; Carrillo-Maravilla E; Pulido-Ramírez AL; Lugo Baruqui D; Hernández-Molina G; Cabral AR
    Rheumatol Int; 2017 Jul; 37(7):1159-1164. PubMed ID: 28474094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
    Resseguier AS; Pereira B; Rieu V; Le Guenno G; Grobost V; Ruivard M
    Lupus; 2017 Oct; 26(12):1297-1303. PubMed ID: 28355988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid syndrome and anticoagulation quality: a clinical challenge.
    Pastori D; Parrotto S; Vicario T; Saliola M; Mezzaroma I; Violi F; Pignatelli P
    Atherosclerosis; 2016 Jan; 244():48-50. PubMed ID: 26584138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Computer aided dosage management of phenprocoumon anticoagulation therapy. Clinical validation].
    Dissmann R; Cromme LJ; Salzwedel A; Taborski U; Kunath J; Gäbler F; Heyne K; Völler H
    Hamostaseologie; 2014; 34(3):226-32. PubMed ID: 24888786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
    Cohen H; Efthymiou M; Devreese KMJ
    J Thromb Haemost; 2021 Apr; 19(4):892-908. PubMed ID: 33325604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies.
    Perry SL; Samsa GP; Ortel TL
    Thromb Haemost; 2005 Dec; 94(6):1196-202. PubMed ID: 16411394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.
    Ruiz-Irastorza G; Khamashta MA; Hunt BJ; Escudero A; Cuadrado MJ; Hughes GR
    Arch Intern Med; 2002 May; 162(10):1164-9. PubMed ID: 12020188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome.
    Efthymiou M; Lawrie AS; Mackie I; Arachchillage D; Lane PJ; Machin S; Cohen H
    Thromb Res; 2015 Jun; 135(6):1191-7. PubMed ID: 25895847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New oral anticoagulants in thrombotic antiphospholipid syndrome.
    Chighizola CB; Moia M; Meroni PL
    Lupus; 2014 Oct; 23(12):1279-82. PubMed ID: 25228726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin monitoring in antiphospholipid syndrome and lupus anticoagulant.
    Crowl A; Schullo-Feulner A; Moon JY
    Ann Pharmacother; 2014 Nov; 48(11):1479-83. PubMed ID: 25104566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature.
    Marco-Rico A; Marco-Vera P
    Semin Thromb Hemost; 2023 Oct; 49(7):736-743. PubMed ID: 36996874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS).
    Woller SC; Stevens SM; Kaplan DA; Branch DW; Aston VT; Wilson EL; Gallo HM; Johnson EG; Rondina MT; Lloyd JF; Evans RS; Elliott CG
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):239-47. PubMed ID: 26566669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-perceived quality of life of primary antiphospholipid syndrome patients using vitamin K antagonist.
    de Oliveira Vaz C; de Moraes Mazetto Fonseca B; Nascimento Silva Vasconcelos PE; Brito Bastos L; Cursino MA; Coelho França Quintanilha J; Tripiquia Vechiatto Mesquita GL; Rosa Dos Santos AP; Cardoso Jacintho B; Oliveira JD; Annichino-Bizzachi J; Andrade Orsi F
    Lupus; 2021 Apr; 30(5):707-714. PubMed ID: 33509064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies.
    Islam MA; Alam F; Wong KK; Kamal MA; Gan SH
    Curr Vasc Pharmacol; 2017; 15(4):313-326. PubMed ID: 28056758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].
    Kondrat'eva LV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Kovalenko TF; Ostriakova EV; Reshetniak TM
    Ter Arkh; 2010; 82(5):33-9. PubMed ID: 20597268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.